Project Details


Critically ill patients develop what is commonly referred to as 'stress diabetes' which is characterized by hyperglycemia and insulin resistance. Intensive insulin treatment (IIT) corrects hyperglycemia, decreases mortality and prevents the incidence of infection and sepsis in critically ill patients. Here we propose that the anti-inflammatory effects of insulin are exerted in part via the brain and would like to provide a rational for modifications to IIT and thus improve the care of critically ill patients.
Effective start/end date1/01/1231/12/16


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.